Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

2-Fluoropyridine-5-Boronic Acid

    • Product Name 2-Fluoropyridine-5-Boronic Acid
    • Alias 2-Fluoro-5-pyridineboronic acid
    • Einecs 602-376-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    312247

    Product Name 2-Fluoropyridine-5-Boronic Acid
    Cas Number 870777-33-6
    Molecular Formula C5H5B FNO2
    Molecular Weight 140.91
    Appearance White to off-white solid
    Purity Typically ≥97%
    Melting Point 210-214°C (decomposition)
    Solubility Soluble in DMSO, slightly soluble in water
    Smiles B(C1=CN=C(C=C1)F)(O)O
    Inchi InChI=1S/C5H5BFNO2/c7-4-1-2-5(3-8-4)6(9)10/h1-3,9-10H
    Storage Conditions Store at 2-8°C, protect from moisture
    Synonyms 2-Fluoro-5-pyridineboronic acid

    As an accredited 2-Fluoropyridine-5-Boronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle, 5 grams, sealed with PTFE-lined cap, labeled with chemical name, CAS number, hazard warnings, and storage instructions.
    Shipping 2-Fluoropyridine-5-boronic acid is shipped in tightly sealed, chemical-resistant containers to prevent moisture and contamination. It is transported as a solid under ambient or controlled temperature conditions, clearly labeled with hazard information. Packaging complies with regulatory guidelines for laboratory chemicals to ensure safe and secure delivery.
    Storage **2-Fluoropyridine-5-boronic acid** should be stored in a cool, dry, well-ventilated place, tightly sealed in its original container to protect it from moisture and air. It should be kept away from direct sunlight, heat sources, and incompatible chemicals, such as strong oxidizing agents. Proper labeling and secure storage are essential to prevent contamination and accidental exposure.
    Application of 2-Fluoropyridine-5-Boronic Acid

    Applications of 2-Fluoropyridine-5-Boronic Acid in Industrial Manufacturing

    2-Fluoropyridine-5-Boronic Acid, as manufactured by our facility, serves as a critical intermediate in various high-value industrial sectors. The following application scenarios detail its authentic downstream roles, formulation specifics, integration points, and compliance with industry benchmarks, supporting manufacturers in regulated environments to meet both performance and regulatory requirements.

    1. Pharmaceutical Active Pharmaceutical Ingredient (API) Intermediate Synthesis

    Leading pharmaceutical companies use this raw material as a key boronic acid coupling partner in the Suzuki-Miyaura cross-coupling step for the assembly of complex heterocyclic scaffolds within active pharmaceutical ingredient (API) synthesis. Its integration supports structures requiring electron-deficient fluoropyridine motifs, especially for kinase inhibitors and oncology candidates. The material is incorporated into the mid-stage of multi-step synthesis, where it is reacted with targeted halogenated pyridines or heteroaryl bromides to build core scaffold backbones with precise regiochemistry.

    Industry compliance standards

    • ICH Q7 GMP Guidelines for Active Pharmaceutical Ingredients
    • US FDA 21 CFR Part 211
    • European Pharmacopoeia (Ph.Eur.) intermediate requirements
    • USP <1121> for synthetic process validation

    Typical usage ratio

    • Added at 1.1–1.5 molar equivalents relative to the aryl halide; specific ratios are adjusted based on throughput calculations and minimization of by-product formation during Suzuki coupling.

    Downstream process integration

    • Material is introduced directly into the palladium-catalyzed cross-coupling reactor after preformation of the activated aryl halide. Post-coupling, subsequent functional group transformations proceed toward crude API isolation.

    Final product types

    • Small-molecule oncology drug APIs
    • CNS active APIs incorporating pyridine fluorine motifs
    • Antiviral agent intermediates
    • Specialty research compounds for drug discovery

    2. Agrochemical Active Ingredient Development

    Formulators within agrochemical R&D utilize this compound in the construction of pyridyl-boronic core intermediates for herbicides and insecticides. It can serve in the synthesis of agrochemicals where the fluoropyridine backbone enhances bioactivity profiles and metabolic stability against plant-pathogen resistance. The raw material enters as a coupling reactant, specifically in steps designed to introduce boronic acid moieties for subsequent oxidative or halogen-derivatization, leading to more potent actives suitable for large-scale crop protection.

    Industry compliance standards

    • OECD Guidelines for the Testing of Chemicals (Synthesis stages)
    • FAO/WHO Good Laboratory Practice for the development phase
    • REACH Annex VII-VIII (Intermediates and substances for plant protection products)
    • SCCS/1618/19: Chemical Safety Assessments for Plant Protection Ingredients

    Typical usage ratio

    • Commonly charged at 0.95–1.2 molar equivalents relative to coupling partners, balancing cost with conversion efficiency for trial and pilot plant runs; ratios can be tuned for batch versus continuous processes.

    Downstream process integration

    • Introduced during the intermediate synthesis phase, immediately following core heterocycle construction; follows Buchwald–Hartwig or Suzuki-Miyaura coupling protocol depending on the target molecule.

    Final product types

    • Herbicide active ingredients with pyridyl-fluorine substitution
    • Selective insecticide intermediates
    • Seed treatment precursor actives
    • Pesticide prototype molecules for resistance management

    3. Electronic Chemical for OLED and Display Materials

    Specialty electronic material developers adopt this boronic acid as a building block in synthesizing small-molecule electron-transport materials and blue-light emitters for high-resolution OLED and flexible display panels. Its fluorinated pyridine structure supports the fine-tuning of electronic properties and thermal stability required in organic electronics. The chemical is introduced to the process via Suzuki-type coupling under inert conditions, primarily for end-group functionalization or to insert tailored electronic features into complex oligomeric or polymeric frameworks during the material design phase.

    Industry compliance standards

    • TÜV Rheinland quality conformance for electronic chemical inputs
    • IEC 62474 for material declaration in electronic modules
    • RoHS Directive (2011/65/EU) for non-restricted substance use
    • ISO 9001:2015 Quality Management Systems for specialty materials

    Typical usage ratio

    • Utilized within a 0.7–1.3 molar equivalent ratio relative to halogen terminated monomers, depending on target molecular weight and desired dopant concentration in device architecture.

    Downstream process integration

    • Charged into the step-growth polymerization reactor following halide monomer dissolution, typically prior to catalyst addition, in controlled atmosphere environments to minimize moisture and oxygen interference.

    Final product types

    • Electron transport materials for OLED displays
    • Organic light-emitting diode (OLED) emitters with blue emission
    • High-purity intermediates for display color filters
    • Electronic-grade functionalized polymers for flexible electronics

    4. Specialty Chemical for Diagnostic Reagent Production

    Medical diagnostic reagent manufacturers deploy this compound during the synthesis of labeled pyridine derivatives and bioactive probes crucial for biochemical assays and imaging kits. The boronic acid group allows efficient conjugation with aryl-based reporter molecules, enhancing signal sensitivity and stability in complex biological matrices. The material is dosed in precisely measured quantities to ensure complete coupling and is incorporated after activation of the halide-labeled biomolecule, serving as the final step before purification and lyophilization of the finished diagnostic probe.

    Industry compliance standards

    • ISO 13485:2016 for Medical Devices Quality Management
    • cGMP for In Vitro Diagnostic (IVD) Manufacturing (21 CFR Part 820)
    • CLSI EP5-A3 for reagent lot consistency and QC
    • WHO Prequalification for Diagnostic Reagents

    Typical usage ratio

    • Measured at 1.0–1.2 equivalents; excess is minimized to eliminate contamination risk in high-purity diagnostic applications, with precise adjustment based on reaction monitoring by HPLC or LC-MS.

    Downstream process integration

    • Added at the final synthesis stage for labeled probe construction, after deprotection or activation steps for the target molecule; purification is done by preparative HPLC followed by lyophilization and QC batch testing.

    Final product types

    • Fluorescent-labeled bio-probes for immunodiagnostics
    • Pyridine-modified capture agents for ELISA kits
    • Small-molecule radiotracer precursors
    • High-specificity reagents for molecular diagnostics

    5. Fine Chemical Intermediate for Photoinitiator Manufacture

    Producers of specialty photoinitiators for UV-curable formulations rely on this intermediate to introduce electron-deficient pyridine rings into custom aromatic photoinitiator molecules. The presence of a fluorine atom imparts desired UV-absorption characteristics and enhances compatibility with acrylate-based systems and inkjet curable coatings. The material is typically incorporated during a Suzuki coupling with halogenated phenyl cores in a solvent system optimized for catalyst life and reactivity.

    Industry compliance standards

    • ISO 22000:2018 (where photoinitiators contact food packaging)
    • ASTM D7767 for ink and coating photoinitiator quality
    • EU Printing Ink Ordinance (1935/2004/EC)
    • REACH registration for use in printing and packaging

    Typical usage ratio

    • Employed in 1.0–1.4 equivalents versus the halogen-containing coupling partner; adjusted based on desired product purity and yield, especially for high-performance coating applications.

    Downstream process integration

    • Added to the main batch reactor post-solvent charge and base addition, prior to catalyst dosing, to ensure full activation and minimize unwanted hydrolysis or side-reactions for photoinitiator synthesis.

    Final product types

    • UV-curable ink photoinitiators with increased reactivity
    • Photoinitiator components for 3D printing resins
    • Specialty coatings initiators for electronics
    • Photoreactive catalysts for advanced composite manufacture
    Free Quote

    Competitive 2-Fluoropyridine-5-Boronic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Understanding 2-Fluoropyridine-5-Boronic Acid from a Manufacturer’s Perspective

    What Sets 2-Fluoropyridine-5-Boronic Acid Apart in Today’s Chemical Landscape

    Every time a new request for 2-Fluoropyridine-5-Boronic Acid crosses my desk, I think back to the early days of our production line when specialty boronic acids were relatively uncommon in custom synthesis labs. In those days, we'd field endless calls about standard boronic acids—phenyl, methyl, and the like—and only a handful of research chemists asked for halogenated pyridine boronic acids with such specific substitutions. Now, 2-Fluoropyridine-5-Boronic Acid stands out more and more as both academic labs and pharmaceutical manufacturers appreciate the edge that subtle structural tweaks can provide in their synthesis routes.

    If you walk down our plant and chat with any of the synthesis team members, you’ll hear a straightforward message: once you start working with fluorinated heterocycles, you realize why they've come into their own in medicinal chemistry and agrochemical R&D. Unlike its non-fluorinated cousins, 2-Fluoropyridine-5-Boronic Acid brings a unique electronic character from the fluorine atom at the ortho position relative to the boronic acid group. This small change impacts how it behaves in Suzuki couplings and related cross-coupling reactions—a fact our technical team has confirmed many times through both pilot batches and large-scale campaigns.

    Why the Demand for Fluorinated Pyridine Boronic Acids Keeps Rising

    More chemists now recognize the role that heterocycle modification plays in fine-tuning biological activity or modifying physical properties to improve absorption, metabolic stability, and target compatibility. The presence of a fluorine atom on a pyridine ring isn’t just a novelty; it can influence hydrogen bonding, membrane permeability, and binding affinity in the final drug molecule. This is why developers in both life science and materials research keep revisiting fluorinated boronic acids. I’ve noticed first-hand that teams handling complex drug lead optimization appreciate how a pre-fluorinated pyridine can simplify downstream functionalization steps, saving them time and cost on protecting group strategies or late-stage halogenation.

    2-Fluoropyridine-5-Boronic Acid may look unremarkable in a catalog, but synthetic chemists know how tough it can be to access reliable, pure materials with this exact substitution. You want the fluorine at the right spot, the boronic acid not prone to polymerization, and minimal contamination from diboronic side products or isomeric impurities. Our plant engineers solved the headaches of reproducible synthesis by tweaking purification steps, using modern crystallization techniques and fine-tuning the aqueous workup to guarantee a consistent, free-flowing product. Each batch is tracked from raw material through final QC, which is why long-term customers keep coming back for project-critical runs.

    The Model We Offer and Its Core Attributes

    We manufacture 2-Fluoropyridine-5-Boronic Acid under the model number FPA-5BA22. After years of troubleshooting process development, this product leaves our facility as a white to off-white crystalline powder, typically presented in sealed glass bottles under inert gas. Material from the current process generally weighs in at over 98 percent purity by HPLC, with water content kept below 0.5 percent, and boronic acid content confirmed with independent titration. We realized early on that trace levels of non-fluorinated or meta-fluorinated impurities can wreak havoc during scalable cross-couplings, which is why each lot undergoes both LC-MS and NMR analysis to approve identity and confirm the fluorine is exactly where specifiers need it.

    Delivering a high-purity intermediate like this isn’t something we take lightly. Any flaw in the purification train or in the final isolation can introduce variability that a synthetic chemist won’t spot until much later—perhaps in a failed final product batch or an unexpected chromatographic separation. I remember a test batch we ran for an agrochemical startup; they flagged a competitive supplier’s material as inconsistent, with about 2 percent regioisomer contamination. That level derailed their scale-up. After switching to our material, their reported yield losses dropped, cycle times shortened, and overall throughput improved—real proof that clean, reproducible intermediates make a difference beyond just the individual reaction vessel.

    Applications Beyond Basic Suzuki Coupling

    Though Suzuki–Miyaura coupling sits at the center of many research and manufacturing processes, we see 2-Fluoropyridine-5-Boronic Acid routinely deployed in contexts that go far beyond the textbook example. One major pharmaceutical client—focused on late-stage neurodegenerative disease therapies—runs complex heterocycle couplings where the pyridine core forms part of a fused aromatic system. In their pipeline, the fluorine substituent proved to alter metabolic clearance rates, resulting in a more favorable pharmacokinetic profile.

    In another project, an electronics company explored new materials for OLED emitters, searching for small variations to tune color purity and carrier mobility. Their R&D team used our boronic acid to build pyridine-fluorine oligomers that showed better stability under operational stress. This sort of anecdote comes up time and again: small changes at the molecular level can drive real advances in both pharmaceuticals and advanced materials, enabled by access to well-produced, reliably supplied building blocks.

    How Our Product Compares with Standard Pyridine Boronic Acids

    Fluorination changes more than just the molecular formula—it shifts physical properties, can increase both lipophilicity and electronic density, and in many reactions lowers the energy required for coupling. By comparison, standard pyridine-5-boronic acid often demands more catalyst or stricter conditions, leading to longer reaction times or more byproduct formation. Fluorine at the 2-position specifically impacts regioselectivity and sometimes opens up routes that wouldn’t work at all with unsubstituted pyridine.

    From experience, we’ve seen process chemists achieve higher yields with less catalyst when working with our fluorinated version. They often report that reaction cleanups require less silica and solvent, thanks to cleaner separation profiles—a detail that makes large-scale campaigns more economically attractive. Sourcing from our facility also means that customers see less lot-to-lot fluctuation in melting point and solubility profile. These small details have real implications for anyone working with hundreds of grams or more, where a tiny variation in impurity profile can scale up to a significant problem.

    Sustainable Production as a Core Focus

    We view environmental stewardship as integral to every batch we ship. Early processes for halogenated boronic acids relied on harsh reagents and could generate persistent waste. Our development chemists spent long hours seeking greener alternatives that didn’t sacrifice yield or selectivity. By improving our solvent recovery, switching to low-impact organometallic reagents for the initial fluorination step, and moving much of our aqueous workup into closed-loop systems, we’ve reduced overall waste by over 60 percent across our multi-kilogram runs.

    This commitment matters not just for in-house safety or regulatory compliance, but also for downstream partners—pharma and materials companies alike—who increasingly scrutinize raw material sustainability. Suppliers that demonstrate clean, efficient, and reproducible syntheses enable their downstream supply chains to hit ambitious ESG goals, push for cleaner reaction protocols, and ultimately spend less time on route remediation. After all, it’s not just about selling a chemical; it’s about ensuring reliability and responsibility from the very first kilogram produced to the final gram used in a research breakthrough.

    Handling, Packaging and Supporting Research Needs

    Good packaging matters more than most realize. Boronic acids, especially those carrying electron-withdrawing groups like fluorine, can sometimes hydrolyze or aggregate unless stored under carefully controlled conditions. We never ship out 2-Fluoropyridine-5-Boronic Acid in flexible pouches or basic HDPE vials. Instead, our product always gets sealed into glass containers, purged with argon, and secondary packed with moisture indicators.

    Our technical support line isn’t just for emergencies. Chemists and process engineers regularly check in to discuss long-term storage, compatibility with their particular bases or solvents, or troubleshoot unusual reactivity. One client recently consulted us regarding changes in crystallinity at scale. By sharing data from our own pilot batch analytics, we helped optimize their drying and storage routines—saving both their material and their schedule.

    Continuous Improvement: Listening to Feedback and Adding Value

    It’s never enough to simply meet an initial product spec. As both pharma and advanced materials research move faster, most labs expect their suppliers to adapt alongside them. If a formulation chemist calls our production floor with concerns about particulate content or reactivity trends observed in their setup, we ask for as many details as they can share, then try to reproduce those results in house. That loop feeds directly into process improvement—sometimes changing the way we refine crystals, sometimes tuning our oven drying steps, occasionally even adjusting the order of intermediary additions in the batch cooker.

    Because we make our own boronic acid from raw reagents, not as a purchased intermediate, we control the full lifecycle—meaning we spot quality deviations before our customers do and make corrections batch-to-batch based on both internal analytics and external feedback. Some competitors might repackage material or cut corners with third-party QA; we believe the extra effort on in-house controls speaks for itself in end-user reports and ongoing reorders.

    Research Trends: Where Next for 2-Fluoropyridine-5-Boronic Acid?

    Even as applications expand, the requests we field keep shifting in emphasis. Life science researchers once focused on core scaffold modifications; now they often experiment with late-stage fluorination, isotope labeling, or apply boronic acids as conjunctive partners for more exotic catalysis—such as photoredox-initiated transformations, flow chemistry, or metal-free coupling under mild conditions. This makes product traceability and consistency even more central, since minor variability can translate into false leads or lost time.

    Industry shifts also drive demand. The regulatory environment for raw materials tightened sharply, pushing analysts to document every step and every raw material. We see more requests for batch certificates and full impurity profiles than ever before. This investment pays back when customers face health authority inspections; data-rich, traceable supply chains minimize their risk.

    The Difference Only Direct Manufacture Delivers

    As a direct manufacturer, our team controls every stage from starting reagent to final shipment. This approach supports true transparency for every batch and means any client questions get answered by the people who developed, optimized, and produced their material—not disconnected resellers. Chemists stop in our plant, walk the process, or audit our records as needed.

    Over the years, this open-door policy built trust with teams not just from pharma giants but smaller specialty research outfits, too. A university group developing next-generation ligands for asymmetric catalysis relied on our regular analytical feedback loops to tweak their own purification protocols. These practical partnerships set us apart from brokerage-only suppliers who can’t provide insight beyond third-party documentation.

    Technical Insights Gathered Over Years of Experience

    Handling 2-Fluoropyridine-5-Boronic Acid at bench and plant scale taught us plenty of hard-won lessons. Pyridine-based boronic acids tend to absorb water from air, but the fluorinated variant seems more prone to gradual color change under high humidity. Our warehouse moved to climate-controlled storage not just to meet regulatory compliance, but because years of QC data showed that shelf stability doubled under these conditions.

    Solubility testing in a range of standard solvents—DMF, dioxane, ethyl acetate, dichloromethane—helped our customer base design both small-scale screens and full production runs. For those tackling difficult purifications, our technical support provides case histories on solvent selection and maximizing recovery, often leveraging internal R&D pilot results.

    Supporting Process Scale-Up: Lessons from The Factory Floor

    Scaling up from a gram in a flask to a multi-kilo batch in a reactor exposes weaknesses you never see in the lab. We’ve endured clumping, off-gassing, filtration slowdowns, and a host of unforeseen quirks. Some of our breakthrough process tweaks—such as reducing batch agitation rate, adjusting pH during workup, or switching to a higher-purity fluorinating agent—came directly from hands-on troubleshooting during scale-up campaigns.

    Our customers directly benefit: not just in fewer process hiccups, but in actionable knowledge on how best to handle, store, and use each batch. Sharing the details of successful campaigns, or dissecting the root cause when things go wrong, means less downtime all around and consistently clean product reaching the end user.

    The Real-World Value of a Reliable Supply Partner

    Whether working with high-throughput screening in a startup lab or multi-ton campaigns for core pharmaceuticals or advanced materials, reliable supply can make or break project timelines. One missed or delayed lot can ripple through an organization, stalling months of work. Knowing your boronic acid comes direct from source, not through layers of traders or third-party packagers, gives peace of mind. Our customers never have to chase answers about what’s in the bottle or how it was made—the record-keeping, the people, and the chemistry are transparent and accessible every step of the way.

    We stay focused on making 2-Fluoropyridine-5-Boronic Acid not just a commodity, but a critical enabler for synthetic breakthroughs. Each improvement, each feedback cycle, and each quality check reflects our experience and commitment to practical manufacturing and customer success.